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Abstract. In a pilot study on acute ischemic stroke (AIS) patients, unexpected periodic fluctuations in micro-
vascular cerebral blood flow (CBF) had been observed. Motivated by the relative lack of information about the
impact of the emergence of breathing disorders in association with stroke on cerebral hemodynamics, we
hypothesized that these fluctuations are due to apneic and hypopneic events. A total of 28 patients were
screened within the first week after stroke with a pulse oximeter. Five (18%) showed fluctuations of arterial
blood oxygen saturation (≥3%) and were included in the study. Near-infrared diffuse correlation spectroscopy
(DCS) was utilized bilaterally to measure the frontal lobe CBF alongside respiratory polygraphy. Biphasic CBF
fluctuations were observed with a bilateral increase of 27.1% 17.7% and 29.0% 17.4% for the ipsilesional
and contralesional hemispheres, respectively, and a decrease of −19.3% 9.1% and −21.0% 8.9% for the
ipsilesional and contralesional hemispheres, respectively. The polygraph revealed that, in general, the fluctua-
tions were associated with apneic and hypopneic events. This study motivates us to investigate whether the
impact of altered respiratory patterns on cerebral hemodynamics can be detrimental in AIS patients. © The
Authors. Published by SPIE under a Creative Commons Attribution 4.0 Unported License. Distribution or reproduction of this work in whole or in
part requires full attribution of the original publication, including its DOI. [DOI: 10.1117/1.NPh.6.2.025004]
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1 Introduction
Most interventions during the early hours after ischemic stroke
onset aim to maximize and stabilize cerebral blood perfusion to
diminish the neurological damage and improve the long-term
outcome.1 Furthermore, these patients could be at risk of pos-
sible detrimental cerebral blood flow (CBF) fluctuations in the
case, for instance, of undiagnosed breathing disorders (BDs).
Disordered breathing includes a range of respiratory disorders,2
often during sleep, characterized by repetitive reduction (hypo-
pneas) or cessation (apneas) of airflow.
Different types of BDs with different physiological origins
have been reported in association with stroke in 10% to 70%
of the patients.3–12 However, it is not yet clear if the presence
of a BD is associated with the long-term outcome. Although
some works support the idea that BDs are associated with
poor recovery from stroke,10,13–16 one study has reported that
BDs in stroke patients are associated with early neurological
worsening but not with long-term outcome at 6 months.4 The
reason for the divergence of the results of these studies could
be not only the physiological origin of BDs (upper airway
obstruction, heart failure, disease, or injury involving the
brain)17 but also the possible, variable amount of detrimental
impact of these events on the cerebral hemodynamics. Thus,
the diagnosis, the quantification of these respiratory events,
and the characterization of their effect on the cerebral hemo-
dynamics may be relevant for the management of the ischemic
stroke patients.
The dynamics of local, microvascular CBF are particularly
interesting as, hypothetically, they could reveal that large,
repeated changes in the cerebral perfusion could be detrimental
when cerebral autoregulation is damaged in the acute stages of
stroke.18 This is relevant during these acute stages as ischemia in
the brain is a potentially reversible process dependent on the
restoration of the microvascular CBF in the penumbra within
a time window of cellular viability that varies on duration
and severity of CBF cessation.19 However, if cerebral autoregu-
lation is damaged, CBF can abruptly increase or decrease with-
out following the needs of the brain and without restoring the
needed CBF in the penumbra. If so, BD treatment could be used
to avoid these unwanted changes. However, there are no estab-
lished methods to monitor microvascular CBF at the bedside.
In non-stroke subjects, cerebral hemodynamic fluctuations
due to apneas or hypopneas have been extensively studied
and characterized previously by several groups by measuring
the cerebral blood flow velocity (CBFV) in the middle cerebral
artery by transcranial Doppler ultrasound (TCD).20–24 However,
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macrovascular CBFV is only an indirect measurement of what
happens in the distal microcirculation.
Fluctuations of cerebral hemodynamics have previously been
observed in acute stroke patients. A study of nine patients with
acute stroke25 reported arterial desaturations from unknown ori-
gin that correlated with cerebral hemodynamics measured with
near-infrared diffuse optical spectroscopy (NIRS-DOS), and
showed an asymmetry of the changes in the two cerebral hemi-
spheres. Pizza et al.26 observed in seven patients with acute/sub-
acute middle cerebral artery stroke that obstructive and central
apneas were linked to cerebral oxygenation changes by NIRS-
DOS. Asymmetrical patterns of cerebral hemodynamic changes
were again found with significantly larger changes on the unaf-
fected hemisphere compared to the affected one. However,
neither NIRS-DOS nor TCD provide a direct measure of micro-
vascular CBF.
In this pilot study, we have utilized diffuse correlation spec-
troscopy (DCS), which uses the speckle statistics of near-infra-
red diffuse light to noninvasively monitor local, microvascular
CBF.27–29 DCS does not need any exogenous tracers and has
been validated against different modalities.29,30 In previous stud-
ies,31 we have observed unexpected fluctuations of microvascu-
lar CBF, heart rate (HR), arterial oxygen saturation (SpO2), and
end-tidal carbon dioxide in three (18%) of the seventeen acute
ischemic stroke (AIS) patients during the first week from stroke
onset, which has motivated the design of this study to investigate
the origin of these fluctuations. Here, we have aimed to test the
hypothesis that these cerebral and systemic fluctuations were
associated with apneic and hypopneic events after stroke.
2 Methods
This study was conducted at the Stroke Unit of Hospital de la
Santa Creu i Sant Pau, in Barcelona, Spain, from August 2016
to March 2017. The study protocol was approved by the local
ethical committee (EC/15/130). Either the patients or their rel-
atives gave their informed written consent.
The inclusion criteria were being older than 18 years, con-
firmed ischemic stroke in the anterior circulation, measurement
time ≤7 days from the stroke onset and written informed con-
sent. The exclusion criteria were resting HR <40 or >110 beats
per minute (bmp), SpO2 <92%, use of oxygen therapy, sympto-
matic lacunar stroke, previous diagnosis of BDs, previous tran-
sient ischemic attack, minor stroke, or intracranial hemorrhage.
The study included two different parts (see Fig. 1, for a flow
chart of the procedure). First, patients who fit the clinical inclu-
sion criteria were screened with a pulse oximeter for a minimum
of 4 h between 8 am and 2 pm. Afterward, if the pulse oximeter
showed periodic decreases of ≥3% in SpO2, the patients were
measured in the afternoon with DCS and also with a respiratory
polygraphy device simultaneously for 1 h in the most comfort-
able head-of-bed position for the patients.
2.1 Neurological Evaluation
Baseline examinations included the collection of a summary of
the medical history from patient records (demographics and vas-
cular risk factors) and a clinical examination. The stroke severity
was assessed with the National Institutes of Health Stroke Scale
(NIHSS)32 on admission and right after the measurement.
Indirect ischemic signs were evaluated by the Alberta Stroke
Program Early Computed Tomography Score (ASPECTS).33
Long-term outcome was evaluated at 3 months by means of
the modified Rankin Scale (mRS)34 where a score of >2 was
considered indicative of an unfavorable outcome.
The extent and location of the ischemic area along with the
site of arterial occlusion were evaluated on admission by a cranial
computed tomography scan and vascular imaging either by
angio-computed tomography or by TCD. If patients were eligible,
reperfusion therapy (thrombolysis or thrombectomy) was
applied.35 Recanalization (either by spontaneous or by revascula-
rization treatment) was assessed with TCD within 24 to 48 h.
The neurological scales were scored by a neurologist or
a senior neurology resident blinded to the optical information.
2.2 Optical Methods and Instrumentation
We have used a custom-built DCS,27 which was previously
described in other protocols within the same collaboration.36–39
Two optical probes were placed on the forehead bilaterally on
both hemispheres as lateral as possible, avoiding the sinuses.
These probes consisted of a bundle of four detector fiber set at
2.5 cm from a source fiber. We have measured the blood flow
index (BFI) continuously with a 2.5-s temporal resolution. The
relative CBF changes were obtained by normalizing the calcu-
lated continuous BFI with the mean BFI of the first 5 min (base-
line) of the measurement. Also, the CBF changes per event were
calculated, as explained in Sec. 2.3.
2.2.1 Pulse oximetry and respiratory polygraphy
A standard pulse oximeter (CMS-50D Plus, CONTEC Medical
Systems CO, Qinhuangdao, China) was used for the screening
of the stroke patients. If these patients were eligible, then they
Fig. 1 Methodology of the two parts of the study. The subjects included in each part are depicted in gray.
SpO2, arterial oxygen saturation.
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were enrolled for the full study which, in addition to DCS,
included a respiratory polygraphy monitoring (Embletta MPR
PG, Natus Medical, Middleton, Wisconsin).
The respiratory polygraphy included the recording of the
oronasal flow (by a thermistor and a nasal cannula), the thoracic
and the abdominal movements (by a respiratory inductance
plethysmography band), the SpO2 and the HR (both by pulse
oximetry), among others. The respiratory polygraphy data
were further postprocessed by a pulmonologist to determine
the following variables: the start and end time points of each
event, the event type (obstructive apnea, hypopnea, mixed
apnea, or central apnea), the 3% oxygen desaturation index
(ODI3), and the number of apneic and hypopneic events per
hour of study (AHI).40
2.3 Statistical Analysis
To calculate the percentage of CBF change (ΔrCBF) due to each
apneic or hypopneic event, we have estimated a basal BFI
(BFIbl) as the average of the cerebral BFI from 30 s before
the apnea/hypopnea start up to 30 s after the event end. This
was considered to correct for slight changes in the probe posi-
tion during the measurement. Afterward, the CBF changes were
calculated as ΔrCBF ¼ ð BFI
BFIbl
− 1Þ × 100. Similarly, ΔHR was
defined as ΔHR ¼ HR − HRbl and ΔSpO2 was defined as
ΔSpO2 ¼ SpO2 − SpO2bl. In all cases, the subscriptbl indicates
an average over the same period.
Afterward, the events were parametrized for the characteri-
zation of the induced ΔrCBF, ΔHR, or ΔSpO2 for each event.
The goal was to study if individual apneic or hypopneic events
were associated with significant increases or decreases in these
variables as it was hypothesized. This step consisted in consid-
ering each event as a function dependent on time [ΔrCBFðtÞ,
ΔHRðtÞ, and ΔSpO2ðtÞ], and then, the extrema of these func-
tions along a specific time interval were calculated. The refer-
ence time (time zero) was considered as the end of each event.
The time windows to find these extrema were considered from
−5 to 15 s for the first extremum on ΔrCBF (see Fig. 2, as an
example), from 0 to 15 s for the ΔHR, and from 5 to 35 s for the
ΔSpO2. These time windows were chosen by visual observation
of all the apneas and hypopneas plotted together from −30 to
60 s and according to the literature.20,41 These analysis methods
have previously been verified in nocturnal measurements of
chronic obstructive sleep apnea patients.42
Averages and standard deviations have been performed con-
sidering all apneic and hypopneic events for each patient and
also for the population. The Wilcoxon signed-rank test was
used to assess the difference between ipsilesional and contrale-
sional ΔrCBF responses. The same test was used to assess if the
apneic/hypopneic response of different variables was signifi-
cantly different from zero. All analyses were performed with
MATLAB (Mathworks, Natick, Massachusetts). A p-value
<0.05 was considered to be statistically significant.
3 Results
During the 8-month period, we have screened 28 ischemic
stroke patients with pulse oximetry, of whom 5 (n ¼ 5, 18%)
presented fluctuations (≥3%) in SpO2 and were then included
in the second part of the study. Table 1 shows the clinical char-
acteristics of these five patients. Four were male, had an age of
81 6 years (mean  standard deviation), an admission
NIHSS of 8 (2, 16) [median (first quartile, third quartile)],
and a time from stroke onset to measurement of 4 (3, 5) days.
Table 2 shows the results of the DCS and the respiratory
polygraphy measurements. In all five patients, the respiratory
polygraphy confirmed the presence of altered breathing pat-
terns; two presented periodic breathing [cases 1 and 3; clusters
of breaths separated by intervals of apnea (no breathing) or
hypopnea], two presented a predominance of obstructive and
hypopneic events (cases 2 and 4; the airflow ceased or partially
ceased due to upper airway obstruction), and one presented cen-
tral apneas (case 5; the airflow ceased or partially ceased due to
diminished or absent effort to breath).
Figure 3 shows a representative trace (from case 4) of 10 min
of continuous oronasal flow, abdominal and thoracic move-
ments, HR, SpO2, and CBF changes. This specific interval
shows two types of events with good signal-to-noise ratio in
the optical data and a “close-up” revealing details. Both apneic
(four obstructive apneas, green shading) and hypopneic (three,
yellow shading) events are visible and the simultaneous moni-
toring shows time correlated variation of microvascular CBF,
HR, and respiratory variables. From the polygraphy recording,
oronasal flow appears to be reduced during the hypopneas and
ceases during the obstructive apneas, whereas abdominal and
thoracic movements are reduced during these events. HR does
not follow a general pattern for this trace. SpO2 shows a drop
with a delay relative to the apneic/hypopneic event. In this time
period with frequent events, as commonly observed, the SpO2
drop of the previous event is overlapped with the next event. It
can also be observed that the CBF reaches its maximum at the
end of an event. Finally, for this specific interval, periodic
breathing is diagnosed but the rest of the acquisition is domi-
nated by obstructive apneic events, as shown in Table 2.
On the contrary, Fig. 4 shows 10 min of similar traces where
neither fluctuations nor apnea/hypopnea events are found. This
patient (case 3) is the only one with no apneic/hypopneic events
during those 10 min.
For completeness, the full data set for the five patients can be
found in Sec. 5 Appendix.
From the five patients, 239 (n ¼ 239) apneic/hypopneic
events were analyzed. In all patients, the CBF changes were
biphasic. In other words, significant bilateral CBF increases
of 27.1% 17.7% (p < 0.001) for the ipsilesional and 29.0%
17.4% (p < 0.001) for the contralesional hemispheres were fol-
lowed by decreases of −19.3% 9.1% (p < 0.001) for the ipsi-
lesional and −21.0% 8.9% (p < 0.001) for the contralesional
Fig. 2 Cerebral blood flow characterization of individual sleep events,
where the apnea end is considered as a pivot point. The light gray
region indicates the sleep event. The dark gray region indicates
the time window used for finding the first extremum value. The first
and second extrema are labeled in blue.
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hemispheres were found due to each apneic/hypopneic event.
There was no interhemispheric difference between the maxi-
mum increases (p ¼ 0.189) or the maximum decreases
(p ¼ 0.053). However, this result suggested a trend toward a
potential difference between hemispheres, as it has been previ-
ously found by NIRS-DOS,25,26 as mentioned in Sec. 1. Also, as
expected, HR increased (p < 0.001) by 6.5 6.8 bpm and SpO2
decreased (p < 0.001) by −4.9% 16.8%.
The two patients (cases 4 and 5) with the highest AHI, one
with predominance of an obstructive apnea pattern and the other
with predominance of a central apnea pattern, had the two high-
est NIHSS both on admission and after the measurement and the
lowest ASPECTS. Unfortunately, both had a mRS of 6, i.e., they
had died during the 3 months after stroke onset. Of these two
patients, the one with the highest AHI (case 5) also presented the
lowest left ventricular ejection fraction. However, neither of
these two patients presented the highest physiological or cer-
ebral hemodynamic changes in response to the respiratory
events. One of the characteristics of the remaining three patients
(cases 1, 2, and 3) with lower stroke severity was that they
presented mainly hypopneic events, in comparison to the
obstructive and central apneas found in the two most severe
patients (cases 4 and 5). We note that, given the small popula-
tion, these were just anecdotal statements and should not be con-
sidered generalizable.
4 Discussion
In this study, we have followed up on our previous observation
of unexpected bilateral fluctuations in microvascular CBF in
patients with anterior, cerebral ischemic stroke that were
observed in different protocols with DCS measurements.31
We have hypothesized that these fluctuations were due to
BDs, in particular, due to apneic and hypopneic events.
Therefore, a protocol based on prescreening for these events
with a pulse oximeter was introduced to enroll patients without
a previous diagnosis of BDs for follow-up study combining res-
piratory polygraphy and DCS. A careful evaluation was carried
out to identify the origin of these fluctuations and to characterize
their details by combining this recording of different respiratory
variables, SpO2, and HR. Apneic and hypopneic events were
determined to be associated with the effect of cerebral hemo-
dynamics and this effect was characterized.
Table 1 Demographics and prestroke clinical characteristics (top) and poststroke clinical characteristics (bottom) of the five ischemic stroke
patients.
Case 1 2 3 4 5
Age (y), gender (M/F) 83, F 73, M 82, M 89, M 76, M
Smoking Former Former Former Former Former
Arterial hypertension Yes Yes No No No
Dyslipidemia Yes Yes No No No
Diabetes No No Yes No Yes
Ipsilesional ICA stenosis >70% Yes No No — No
Coronary disease No No Yes No Yes
Atrial fibrillation No No No No No
Left ventricular ejection fraction (%) >50 40 to 50 40 — 25
Arterial occlusion Left MCA Left MCA Right ACA Left MCA Right MCA
NIHSS admission 7 7 3 20 21
NIHSS after the
measurement 2 1 8 16 21
Reperfusion therapy Yes Yes No No No
Recanalization Yes No Yes No No




ASPECTS 8 8 10 6 6
Days from stroke to measurement 7 4 3 5 0
mRS 3 months 2 1 4 6 6
Note: M, male; F, female; ICA, internal carotid artery; MCA, middle cerebral artery; ACA, anterior cerebral artery; NIHSS, National Institutes of
Health Stroke Scale; ASPECTS, Alberta Stroke Program Early Computed Tomography Score; and mRS, modified Rankin Scale.
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As observed by the full data set in the Sec. 5 Appendix, the
precise nature of the cause of the microvascular CBF changes is
not absolutely clear from this study, i.e., some CBF fluctuations
lead the apnea/hypopnea, whereas others follow it. This may be
partially due to errors in the precise synchronization of the mea-
surements but it may also have further implications indicating
secondary events that may have caused respiratory effects, such
as cortical spreading depression43–45 in the brain stem.46,47
However, our study did not gather definitive evidence (e.g.,
recordings at multiple locations to demonstrate any spreading
activity and/or recordings of the electrical activity) to accept
or refute this possibility. These results have encouraged us to
look further and deeper into this issue in future studies by com-
bining multimodal, precisely synchronized diffuse optical
recordings with polygraphy, capnography, and electroencepha-
lography, and a larger head coverage with multiple source and
detector pairs.
By the polygraphy, HR and SpO2 changes were found during
these events. These HR and SpO2 changes followed the apneic/
hypopneic dynamics expected by the literature in patients with
BDs,20,24,41,48,49 showing an increase during the event or at the
end of it for the HR, and a decrease after the end of the event for
the SpO2. No periodicity in the respiratory changes was found,
as shown in the full data set in Sec. 5 Appendix, as the perio-
dicity depended on the pathogenic mechanism, on the sleep
stage, and on the position, among others.50
In non-stroke patients with BDs, several studies have
reported CBFV changes measured by TCD as showing an
increase close to the end of the apnea.20,23,24 Our findings are
similar; we have observed a CBF increase of 27.1% 17.7%
and 29.0% 17.4% for the ipsilesional and contralesional
hemispheres, respectively, and a decrease of −19.3% 9.1%
and −21.0% 8.9% for the ipsilesional and contralesional
hemispheres, respectively, close to the end of the apneic/hypo-
pneic events. This increase is similar to the CBF increase of
30% 17% and the decrease of −20% 12% described previ-
ously by us using DCS in obstructive sleep apneic events.42 It is
also consistent with the CBFVof 22% to 42% increase found by
Alex et al.23 and also to the 14.6% 14% increase right after the
apnea end by Bålfors and Franklin.20 However, other authors
have found larger CBFV increases.21,24
These results show that there is a decrease in cerebral perfu-
sion due to an apneic or hypopneic event. If these intermittent
decreases lead to ischemia, they can cause hypoxic/ischemic
brain injury, especially if cerebrovascular reactivity and regula-
tion are impaired, which is often the case in ischemic stroke
patients.51,52 Consequently, this could lead to a worsened progno-
sis, which may call for interventions such as continuous positive
airway pressure (CPAP) therapy. We note that, to date, no direct
link among a degree of microvascular CBF changes, the long-
term outcome, and the use of CPAP therapy has been studied.
Several works have studied the general effect of CPAP
therapy, mainly in obstructive disorders or adaptive servo-ven-
tilation (ASV) treatment for central disorders to avoid apneas
and hypopneas.53–55 In stroke patients, whereas some authors
support the benefits of the CPAP treatment on BDs,15,56–61 others
claim that these benefits are not clear62,63 or that there is no ben-
efit at all.64 Nevertheless, as mentioned earlier, BDs diagnosis
and CPAP or ASV treatment are not the common practice in the
stroke units.
Table 2 Polygraphic characteristics (top) and maximum CBF, HR and SpO2 changes due to each apneic/hypopneic event (bottom) of each
patient.
Case 1 2 3 4 5
AHI (n∕hour) 45.6 13 24.8 45.8 63.8
ODI3 (%) 46.3 15.7 17.4 48.1 10
Obstructive apneas, n 0 0 1 31 1
Central apneas, n 1 0 2 0 82
Mixed apneas, n 0 0 1 0 0
Hypopneas, n 37 13 20 30 0
Event duration (s) 21 7 24 4 27 8 30 11 19 5
BD Periodic respiration Hypopneas Periodic respiration Obstructive events Central apneas
Max. increase-induced ΔrCBFipsi (%) 30.0 12.7 37.4 13.0 22.4 8.9 31.0 10.1 21.9 23.9
Max. increase-induced ΔrCBFcontra (%) 32.9 21.4 27.6 11.0 29.7 15 36.1 11.2 21.7 18.3
Max. decrease-induced ΔrCBFipsi (%) −19.2 7.0 −33.3 12.1 −16.1 8.2 −24.2 6.6 −13.6 5.8
Max. decrease-induced ΔrCBFcontra (%) −17.8 7.4 −25.4 11.1 −19.9 8.1 −28.0 8.1 −16.3 5.3
Max. increase-induced ΔHR (bpm) 2.8 1.6 14.8 8.0 16.0 6.8 10.6 4.3 1.1 0.7
Max. decrease-induced ΔSpO2 (%) −2.2 1.0 −1.6 0.7 −1.5 9.3 −9.9 24.6 −0.9 0.8
Note: AHI, apnea–hypopnea index; ODI3, 3% oxygen desaturation index;ΔrCBF, relative cerebral blood flow changes;ΔHR, HR changes;ΔSpO2,
arterial oxygenation saturation changes; Max., maximum; ipsi., ipsilesional hemisphere; contra., contralesional hemisphere; and n, number of
events detected; mean±standard deviation.
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Future work with a larger sample size to investigate if the
CPAP or ASV could be effective in those patients who show
the presence and/or large fluctuations in CBF (e.g., above a
threshold) in relation to apneic/hypopneic events is warranted.
In addition, it would be of interest to study if all ischemic stroke
patients with apneic/hypopneic events show similar CBF fluc-
tuations, or if there is an interindividual variability in the
response to apneas or hypopneas, and, consequently, the
response to treatment may be different.
In our cohort, the two patients (cases 4 and 5) with the high-
est AHI were those with the worse stroke severity (higher
NIHSS score) at the moment of the measurement. This has
been previously reported in patients with stroke showing central
BDs.13 Similarly, the ASPECTS score of these two patients were
the lowest of the group, which was compatible with the idea that
large acute cerebral hemispheric lesions were associated to
BDs.7,65 One of these two severe patients (case 5; case 4 had
no information available) presented heart failure [low left ven-
tricular ejection fraction (<40%)] and mainly central events, as it
has been found in stroke patients in association with central
BDs.6 The BD present in this patient could be related to it.
Insular and frontal ischemic regions were present in our cohort
and, interestingly, these regions have already been associated to
BDs of central origin.13,65,66 However, other works have sup-
ported the idea of the lack of an association between the pres-
ence of BDs of central origin and the location of stroke.5,9,11
Nevertheless, more patients are needed to clearly identify clini-
cal associations.
Our proof-of-concept study has some limitations, including
the small number of patients included in the final analysis, the
different types of possible BDs with different physiological ori-
gins, and the short recording time of DCS simultaneously with
respiratory polygraphy. Future studies will add more subjects
and will measure these subjects during several hours continu-
ously in order to better identify the type of BD, and moreover,
to link it to the degree of the cerebral hemodynamic responses,
among other previously mentioned goals.
Another limitation is that only one measurement per
patient has been performed for this study, so we could not
track the start and cessation of the fluctuations together
with the clinical stroke evolution. Anecdotally, in our previous
protocols,31,67 the physiological fluctuations observed have
Fig. 3 A 10-min trace of systemic fluctuations of physiological variables alongside the fluctuations of
CBF. Red and black CBF traces correspond to the ipsilesional and contralesional hemispheres, respec-
tively. Hypopneas (yellow) and obstructive apneas (green) are shown from the measurements of an 89-
year-old male with a left middle cerebral artery ischemic stroke (case 4). The patient presented a left
middle cerebral artery stroke with insular, temporal, and basal ganglia ischemic areas. The NIHSS
score was 16 when measured. The patient died after 24 h of the measurement.
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prevailed in the different measurements performed in each
patient during the first week after stroke. Accordingly, it is
expected that BDs could be present during the first week
after stroke in the case of patients with BDs of central origin,
as BDs have been found to resolve after several weeks.66
Future studies should include daily measurements to track
when these fluctuations cease and to relate it to clinical
parameters.
Owing to the small number of subjects considered for this
analysis, we have avoided a group analysis. Two important
parameters to understand CBF changes are the blood pressure
and the end-tidal carbon dioxide; future studies should include
their simultaneous measurement with DCS. Different studies
have suggested these two parameters as different primary drivers
to the CBFV changes during apneas. Przybylowski et al.68 sug-
gested that carbon dioxide is the primary regulator, and not the
blood pressure, of the rise in CBFV (measured by TCD) during
apnea and in the reduction of CBFV in the following apnea. On
the contrary, Yaggi and Mohsenin69 suggested that if autoregu-
lation is impaired or the changes in blood pressure are suffi-
ciently rapid that an intact autoregulation does not have time
to adapt, then the changes in TCD velocity could be related
to the changes in blood pressure. However, these studies only
focus on the macrocirculation level; on the microcirculation
level, these parameters may have a different influence on micro-
vascular CBF. Moreover, hypoxia has been found during apneic
events,70,71 which could also contribute to the local microvascu-
lar change.
Finally, diffuse optical spectroscopy techniques not only pro-
vide information from the brain but also contain scalp and skull
contributions.29,72 In this work, instead of including a small
source–detector separation (1 cm) to study the superficial
effects, we have kept all detectors for large separations to
focus on improving the signal-to-noise ratio, as a source–detec-
tor separation of 2.5 cm has been found to be a good compro-
mise.29,30,73 Future implementations could utilize more source–
detector pairs as well as a pressure modulation protocol to min-
imize this effect.74
In conclusion, DCS has successfully revealed bilateral fluc-
tuations in CBF of ischemic stroke patients with undiagnosed
BDs, in accordance with systemic fluctuations of physiological
variables. These cerebral hemodynamic fluctuations are related
to apneic and hypopneic events in the five patients tested.
Further studies are needed to study the possible detrimental
Fig. 4 A 10-min trace with no typical fluctuations of cerebral blood and no apneas or hypopneas. Red and
black CBF traces correspond to the ipsilesional and contralesional hemispheres, respectively.
Measurements of an 82-year-old male with a right anterior cerebral artery ischemic stroke (case 3)
are provided. The patient had a blockage of the right anterior cerebral artery with a frontal ischemic
area. The NIHSS score was 8 when measured.
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impact of the magnitude and presence of these cerebral hemo-
dynamic fluctuations, especially in the early hours after stroke
where the interventions are more relevant to the outcome, for the
recovery of stroke patients.
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